HNSA.ST Trial readout: Wednesday, September 30, 2026
CompanyHansa Biopharma AB (HNSA.ST)
EventTrial readout
DateWednesday, September 30, 2026
MarketEU listing
SourceCT.gov registry · confidence 70% · primary source ↗
Est. Completion: 2026-09-30. Status: RECRUITING. Title: Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.